浅表性膀胱癌：最新进展 - Suppr

Suppr

超能文献

Superficial bladder cancer: state of the art.

作者信息

Bono A V

机构信息

Divisione di Urologia, Ospedale di Circolo, e Fondazione Macchi, Varese, Italy.

出版信息

Cancer Chemother Pharmacol. 1994;35 Suppl:S101-9. doi: 10.1007/BF00686931.

DOI:10.1007/BF00686931

PMID:7994780

Abstract

摘要

相似文献

Superficial bladder cancer: state of the art.浅表性膀胱癌：最新进展

Cancer Chemother Pharmacol. 1994;35 Suppl:S101-9. doi: 10.1007/BF00686931.

[Indications for topical therapy in superficial bladder cancer].[浅表性膀胱癌的局部治疗适应证]

Urologe A. 1992 Jul;31(4):201-2.

Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.局部膀胱热疗联合膀胱内化疗治疗高级别浅表性膀胱癌。

Urology. 2004 Mar;63(3):466-71. doi: 10.1016/j.urology.2003.10.036.

Histological grading of carcinoma in situ of the bladder: its clinical significance in patients who underwent intravesical mitomycin C and doxorubicin sequential therapy.膀胱原位癌的组织学分级：其在接受膀胱内丝裂霉素C和阿霉素序贯治疗患者中的临床意义

J Urol. 1996 Jan;155(1):94-8; discussion 98-9. doi: 10.1016/s0022-5347(01)66555-8.

Surgical management of superficial bladder cancer (stages Ta/T1/CIS).

Semin Surg Oncol. 1997 Sep-Oct;13(5):328-34. doi: 10.1002/(sici)1098-2388(199709/10)13:5<328::aid-ssu6>3.0.co;2-f.

Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.丝裂霉素-C和卡介苗在浅表性膀胱癌膀胱内化疗及免疫治疗中的应用。芬兰膀胱研究小组。

Prog Clin Biol Res. 1989;310:271-4.

[Quantitative immunocytology as a marker for indications and follow-up of recurrence prevention of superficial urinary bladder cancers].[定量免疫细胞术作为浅表性膀胱癌复发预防指征及随访的标志物]

Urologe A. 1989 Sep;28(5):289-91.

[Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].[卡介苗辅助膀胱内灌注治疗3级浅表性膀胱癌的结果]

Hinyokika Kiyo. 2004 Nov;50(11):767-71.

Epirubicin in treatment and recurrence prophylaxis of patients with superficial bladder cancer.

Prog Clin Biol Res. 1989;303:423-34.

An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy.浅表性膀胱癌的治疗概述。膀胱内化疗。

Urol Clin North Am. 2000 Feb;27(1):125-35, x. doi: 10.1016/s0094-0143(05)70240-8.

引用本文的文献

Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery.膀胱癌手术前每周使用厄洛替尼的II期临床化学预防试验。

Cancer Prev Res (Phila). 2025 Jan 6;18(1):31-39. doi: 10.1158/1940-6207.CAPR-24-0194.

本文引用的文献

The significance of lamina propria invasion on the prognosis of patients with bladder tumors.

J Urol. 1980 Jul;124(1):23-6. doi: 10.1016/s0022-5347(17)55272-6.

Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report.

Cancer Treat Rep. 1980 Feb-Mar;64(2-3):225-30.

Role of intravesical mitomycin C in management of superficial bladder tumors.膀胱内注射丝裂霉素C在浅表性膀胱肿瘤治疗中的作用。

Urology. 1980 Jul;16(1):11-5. doi: 10.1016/0090-4295(80)90322-2.

Intracavitary Epodyl for multiple non-invasive, highly differentiated bladder tumours.腔内Epodyl用于治疗多发性非侵袭性、高分化膀胱肿瘤。

Scand J Urol Nephrol. 1980;14(1):43-5. doi: 10.3109/00365598009181188.

Factors influencing the recurrence rate of bladder cancer.影响膀胱癌复发率的因素。

J Urol. 1980 Jan;123(1):29-31. doi: 10.1016/s0022-5347(17)55763-8.

DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours.DNA模式、组织学分级及肿瘤数量与浅表性膀胱肿瘤复发率的关系。

Scand J Urol Nephrol. 1982;16(2):135-9. doi: 10.3109/00365598209179742.

Mode of presentation of invasive bladder cancer: reassessment of the problem.浸润性膀胱癌的表现方式：问题的重新评估

J Urol. 1982 Jul;128(1):31-3. doi: 10.1016/s0022-5347(17)52738-x.

Prognostic parameters in superficial bladder cancer: an analysis of 315 cases.浅表性膀胱癌的预后参数：315例病例分析

J Urol. 1982 Feb;127(2):250-2. doi: 10.1016/s0022-5347(17)53725-8.

A controlled trial of single dose intravesical adriamycin in superficial bladder tumours.单剂量膀胱内注射阿霉素治疗浅表性膀胱肿瘤的对照试验。

Br J Urol. 1981 Dec;53(6):585-7. doi: 10.1111/j.1464-410x.1981.tb03266.x.

The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.

J Urol. 1981 Mar;125(3):307-12. doi: 10.1016/s0022-5347(17)55018-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验